| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.098 | 0.07 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.098 | 0.07 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |